Anebulo Pharmaceuticals Inc Share Price

NASDAQ: ANEB

Small Cap

$2.44

-0.06

(-2.40%)

as on September 19, 2025 at 1:29 am IST

$₹

Anebulo Pharmaceuticals Inc Stock Performance

as on September 19, 2025 at 1:29 am IST

Day's Low
Day's High
$2.4
Day's Price Range
$2.53
$2.44
1.64%
Downside
3.69%
Upside
52 Week's Low
52 Week's High
$0.8
52-Week Price Range
$3.42
$2.44
67.21%
Downside
40.16%
Upside

Anebulo Pharmaceuticals Inc share price movements today

Previous Close: $2.50
Open: $2.53
Volume: 125.5K
Day's Low - High: $2.4 - $2.53
52 Week Low - High: $0.8 - $3.42

Anebulo Pharmaceuticals Inc Historical Returns

1 Month Return: -3.1 %
3 Month Return: + 61.29 %
1 Year Return: + 25 %
3 Year Return: -27.75 %
5 Year Return: 0 %

Anebulo Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Anebulo Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$102.3M

EPS (TTM)

-0.25

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

3851600.00%

Anebulo Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anebulo Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Anebulo Pharmaceuticals Inc	BUY	$102.3M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Anebulo Pharmaceuticals Inc Stock including INR - Dollar returns

The Anebulo Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y

Anebulo Pharmaceuticals Inc investment value today

Current value as on today

₹1,26,953

Returns

₹26,953

(+26.95%)

Returns from Anebulo Pharmaceuticals Inc Stock

₹22,000 (+22%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Anebulo Pharmaceuticals Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Anebulo Pharmaceuticals Inc. Average target price of $3

Anebulo Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Anebulo Pharmaceuticals Inc.

What analysts predicted

18.67%UPSIDE

Target Price

$3

Current Price

$2.44

Analyzed by

9 Analysts

Target

$3.00

Anebulo Pharmaceuticals Inc target price $3, a slight upside of 18.67% compared to current price of $2.44. According to 9 analysts rating.

Anebulo Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Anebulo Pharmaceuticals Inc Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 20, 2025 to September 19, 2025

Change:-46% versus previous 30 day period

Anebulo Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-3	-2	-2	-2	-2	-1	-1	-2	-2	-1
EBITDA	-3	-2	-2	-2	-2	-1	-1	-2	-2	-1
Interest Expense	0	0	0	-	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-3	-2	-2	-2	-2	-1	-1	-2	-2	-1
Income Tax Expense	0	0	0	0	0	-1	0	-	-2	-
Net Income	-3	-2	-2	-2	-2	-1	-1	-2	-2	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Anebulo Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Jun 2021	Dec 2021	Jun 2022	Dec 2022	Jun 2023	Dec 2023	Jun 2024
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-
Operating Income	-	-3	-	-6	-	-11	-	-8
EBITDA	-	-30	-	0	-	-11	-	-8
Interest Expense	-	0	-	0	-	-	-	0
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	-	-30	-	-6	-	-11	-	-8
Income Tax Expense	-	0	-	0	-	0	-	-
Net Income	-30	-30	-30	-6	-6	-11	-11	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Anebulo Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Net Income	-2	-2	-2	-2	-1	-1	-2	-2	-1
Operating Cash Flow	-2	-2	-2	-1	-1	-2	-1	-1	-1
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	0	-	0	-	-	-	15	0
Change in Cash	-2	-2	-2	-1	-1	-2	-1	13	-1

Anebulo Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Jun 2021	Jun 2022	Jun 2023	Jun 2024
Net Income	-30	-6	-11	-8
Operating Cash Flow	-4	-5	-9	-8
Investing Cash Flow	-	-	-	-
Financing Cash Flow	21	6	6	0
Change in Cash	16	-5	-3	-8

Global Institutional Holdings in Anebulo Pharmaceuticals Inc

Funds	Holdings
King Luther Capital Management Corp	0%

Insights on Anebulo Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ANEB stock has moved up by 24.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 139.2%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 43.4%

About Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company. It is engaged in developing treatments for cannabis toxicity, such as unintentional cannabis poisoning, acute cannabinoid intoxication (ACI) and the landscape of acute cannabis-induced conditions. Its lead product candidate is selonabant, a potent, small molecule antagonist of cannabinoid binding receptor type-1 (CB1), the primary receptor involved in the psychotropic effects of cannabinoids, with the potential to address the unmet medical need for a therapy to treat cannabis toxicity. Selonabant is orally bioavailable, rapidly absorbed, and has also been formulated for intravenous administration. Selonabant is intended to rapidly reverse the negative effects of cannabis-induced toxicity and reduce time to recovery. It is also prioritizing the advancement of a selonabant intravenous (IV) formulation as a potential treatment for pediatric patients with cannabis-induced CNS depression.

Organisation	Anebulo Pharmaceuticals Inc
Headquarters	1017 Ranch Road 620 South, Lakeway, TX, United States, 78734
CEO	Mr. Richard Anthony Cunningham
E-voting on shares	Click here to vote

Key Management of Anebulo Pharmaceuticals Inc

Name	Title
Dr. Kenneth C. Cundy Ph.D.	Chief Scientific Officer
Dr. Joseph F. Lawler M.D., Ph.D.	Founder & Chairman
Mr. Richard Anthony Cunningham	CEO & Director
Mr. Daniel V. George	Acting CFO & Secretary

FAQs

What is Anebulo Pharmaceuticals Inc share price today?

Anebulo Pharmaceuticals Inc share price today is $2.44 as on September 19, 2025 at 1:29 am IST at the close of the market. Anebulo Pharmaceuticals Inc share today touched a day high of $2.53 and a low of $2.4.

What is the 52 week high and 52 week low for Anebulo Pharmaceuticals Inc share?

Anebulo Pharmaceuticals Inc share touched a 52 week high of $3.42 on July 23, 2025 and a 52 week low of $0.8 on December 20, 2024. Anebulo Pharmaceuticals Inc stock price today i.e. September 19, 2025 at 1:29 am IST is closed at $2.44,which is 28.65% down from its 52 week high and 204.96% up from its 52 week low.

What is Anebulo Pharmaceuticals Inc's market capitalisation today?

Anebulo Pharmaceuticals Inc market capitalisation is $0.00T as on September 19, 2025 at 1:29 am IST.

How to invest in Anebulo Pharmaceuticals Inc Stock (ANEB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Anebulo Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anebulo Pharmaceuticals Inc Shares that will get you 0.6148 shares as per Anebulo Pharmaceuticals Inc share price of $2.44 per share as on September 19, 2025 at 1:29 am IST.

What is the minimum amount required to buy Anebulo Pharmaceuticals Inc Stock (ANEB) from India?

Indian investors can start investing in Anebulo Pharmaceuticals Inc (ANEB) shares with as little as ₹88.114 or $1 (as of September 19, 2025 at 2:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Anebulo Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 19, 2025 at 2:42 am IST). Based on Anebulo Pharmaceuticals Inc share’s latest price of $2.44 as on September 19, 2025 at 1:29 am IST, you will get 4.0984 shares of Anebulo Pharmaceuticals Inc. Learn more about fractional shares .